EUVIMEDEUVIMED entdecken
Crossref

Efficacy and Outcomes of Nitinol Covered Stents for Management of Acute Iatrogenic and Secondary Esophageal Perforation

Vignesh Vudatha, Elizabeth Bashian, Renee Cholyway, Zachary Rollins, Lee Warren, Carlos Puig, Walker Julliard, Rachit D Shah

Journal of Surgical Research · 2025-11 · 315 · 482-487

DOI: 10.1016/j.jss.2025.09.016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Surgical Research, 2025-11. Verfasst von Vignesh Vudatha und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiothoracic Surgery, Department of Surgery, Virginia Commonwealth University Health, Richmond, Virginia. Hauptthemen laut MEDLINE: Esophageal Perforation, Stents, Alloys. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: The objective of this study was to evaluate efficacy and safety of fully covered nitinol esophageal stent for esophageal perforations. METHODS: Patients who underwent esophageal stent placement for esophageal perforation between 2009 and 2021 at a tertiary care center were evaluated retrospectively. Patients requiring esophageal repair and/or mediastinal drainage were included. Stable patients with contained perforation were excluded. In each case, a fully covered esophageal stent was placed under fluoroscopic guidance. In most cases, video-assisted thoracoscopy was performed for mediastinal drainage. Leak occlusion and stent position were confirmed with esophagram postoperatively. Outcomes assessed include stent removal timing, successful healing of the leak, need for additional surgical intervention, and survival. RESULTS: A total of 54 patients underwent stent placement for perforation. The mean age was 63, with 63% (34/54) male preponderance. The most common presenting symptoms were chest pain (48%, 26/54), epigastric pain (20%, 11/54), and shortness of breath (15%, 8/54). Perforations ranged from 1 to 10 cm in length and usually occurred in the lower esophagus (67%, 36/54). Etiology included iatrogenic (44%, 24/54), Boerhaave's (15%, 8/54), oncologic (13%, 7/54), food-induced (11%, 6/54), anastomotic leak (9%, 5/54), and other (7%, 4/54). The majority had concurrent video-assisted thoracoscopy, laparoscopic, or open drainage of the mediastinum (36/54, 67%). 15% (8/54) of patients had stent placed secondarily for perforation/leak. 83% (45/54) of patients had their stents removed with an average removal time of 41 days. 13% (6/46) of patients treated initially with stent required additional surgical intervention. Postoperatively, 10.9% of patients treated primarily with stent (5/46) required an interventional radiology drain and 8.7% (4/46) had stent migration. One migration required a second stent placement, and another required repositioning. 17.3% (8/46) had persistent leak on upper GI study necessitating additional stent (4/8, 50%), percutaneous drainage (2/8, 25%), or resolved spontaneously (2/8, 25%). 95.6% (44/46) survived the hospitalization with median length of stay of 12 days (interquartile range 11). One-year and 2-year survival among patients with a primary stent placement were 84% (26/31) and 79% (19/24) respectively. CONCLUSIONS: Fully covered esophageal stent placement as the initial form of therapy is a safe and effective for managing acute iatrogenic and secondary esophageal perforations, even in the setting of large perforations and severe sepsis. Endoscopic therapy was generally effective at treating complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Esophageal PerforationStentsAlloysHumansMaleFemaleRetrospective StudiesMiddle AgedAgedIatrogenic DiseaseTreatment OutcomeAdultThoracic Surgery, Video-AssistedAged, 80 and overDrainageDevice RemovalPostoperative ComplicationsEsophagus

Stichwörter der Autor:innen

Endoscopic managemenEsophageal perforationtEsophageal stent

Substanzen

nitinolAlloys

Autor:innen und Institutionen

  • Division of Cardiothoracic Surgery, Department of Surgery, Virginia Commonwealth University Health, Richmond, Virginia.
  • Division of Cardiothoracic Surgery, Department of Surgery, Virginia Commonwealth University Health, Richmond, Virginia. Electronic address: Rachit.Shah@vcuhealth.org.

Zitieren

APA

Vudatha, V., Bashian, E., Cholyway, R., Rollins, Z., Warren, L., Puig, C., Julliard, W., & Shah, R. D. (2025). Efficacy and Outcomes of Nitinol Covered Stents for Management of Acute Iatrogenic and Secondary Esophageal Perforation. Journal of Surgical Research, 315, 482-487. https://doi.org/10.1016/j.jss.2025.09.016

Vancouver

Vudatha V, Bashian E, Cholyway R, Rollins Z, Warren L, Puig C, et al. Efficacy and Outcomes of Nitinol Covered Stents for Management of Acute Iatrogenic and Secondary Esophageal Perforation. Journal of Surgical Research. 2025;315:482-487. doi:10.1016/j.jss.2025.09.016

BibTeX
@article{Vudatha2025,
  author = {Vudatha, Vignesh and Bashian, Elizabeth and Cholyway, Renee and Rollins, Zachary and Warren, Lee and Puig, Carlos and Julliard, Walker and Shah, Rachit D},
  title = {Efficacy and Outcomes of Nitinol Covered Stents for Management of Acute Iatrogenic and Secondary Esophageal Perforation},
  journal = {Journal of Surgical Research},
  year = {2025},
  volume = {315},
  pages = {482--487},
  doi = {10.1016/j.jss.2025.09.016}
}
Kostenlos starten →